SCHEMBL16612854

SCHEMBL16612854

COc1ccc2ccn(CCn3c[c]c(C(N)=O)n3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 6/20 0.52
MTNR1B P49286 6/20 0.52
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
MCL1 Q07820 1/20 0.45
HTR7 P34969 1/20 0.45
TRPV1 Q8NER1 1/20 0.44
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
ADA P00813 1/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16612936 0.94 MTNR1A (0.50) MTNR1AMTNR1BHTR2AHTR2CMCL1
SCHEMBL16612868 0.93 MTNR1A (0.49) MTNR1AMTNR1BHTR2AHTR2CHCRTR1
SCHEMBL16612831 0.86 HCRTR2 (0.42) MTNR1AMTNR1BHCRTR1HCRTR2HDAC8
SCHEMBL16612876 0.84 HTR2C (0.41) MTNR1AMTNR1BHTR2AHTR2CHTR7
SCHEMBL16612628 0.83 HCRTR2 (0.43) MTNR1AMTNR1BMCL1HCRTR1HCRTR2
SCHEMBL16612997 0.83 HCRTR2 (0.42) MTNR1AMTNR1BMCL1HCRTR1HCRTR2
SCHEMBL16612954 0.83 LMNA (0.53) MTNR1AMTNR1BHTR2AHTR2CLMNA
SCHEMBL16612656 0.82 HCRTR2 (0.42) MTNR1AMTNR1BHCRTR1HCRTR2HDAC8
SCHEMBL16612856 0.82 MTNR1A (0.54) MTNR1AMTNR1BHCRTR1HCRTR2ALDH1A1
SCHEMBL16613000 0.81 HTR2A (0.42) MTNR1AMTNR1BHTR2AHTR2CMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP claimed